Affiliation:
1. Abnormal Uterine Bleeding Research Center Semnan University of Medical Sciences Semnan Iran
2. Department of Clinical Pharmacy School of Pharmacy Shahid Beheshti University of Medical Sciences Tehran Iran
3. Social Determinants of Health Research Center Semnan University of Medical Sciences Semnan Iran
Abstract
AbstractThis study aimed to evaluate the efficacy and safety of evening primrose oil (EPO) for cervical ripening before gynecologic procedures and compare it to misoprostol. In this study, 40 hysteroscopy and dilation and curettage candidates were enrolled. Patients were randomly assigned to receive either 2000 mg of vaginal EPO (n = 20) or 200 μg of vaginal misoprostol (n = 20) 2 hours before the expected procedure. The measured outcomes were the size of the Hegar dilator that passed through the cervix effortlessly, uterine cervicovaginal complications, and drug‐related side effects. The two groups were not significantly different in age, number of gravity, parity, type of delivery, and menopausal status (P > .05). The mean ± SD size of the first dilator was 5.25 ± 1.55 in the misoprostol group and 7.30 ± 1.08 in the EPO group (P < .001). The pain complaint in the EPO group was significantly lower (P = .027), but the two groups were not significantly different in terms of other complications. No cases of uterine or cervical rupture were seen in either group. The present study showed that 2000 mg of vaginal EPO was significantly more effective for cervical ripening than 200 μg of vaginal misoprostol before gynecological surgery. Therefore, it is recommended to use EPO as an alternative to misoprostol.
Subject
Pharmacology (medical),Pharmacology
Reference32 articles.
1. Overcoming the Challenging Cervix: Identification and Techniques to Access the Uterine Cavity
2. A systematic review and meta-analysis of randomized controlled trials on the effectiveness of cervical ripening with misoprostol administration before hysteroscopy
3. Preoperative ripening of the cervix before operative hysteroscopy;Al‐Fozan H;Cochrane Database Syst Rev,2015
4. Comparison of vaginal misoprostol, combined letrozole and misoprostol and combined laminaria and misoprostol in the preparation of second‐trimester cervical abortion;Kahnamooi F;J Ardabil Univ Med Sci,2018